...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Great surge in PPS for fellow RVX investers

true :) one can only hope.  Really enjoy reading your posts bear.

Share
New Message
Please login to post a reply